Abstract
The determination of the extent of the non-viable tissue after myocardial infarction has a major impact on further treatment of patients. During acute myocardial infarction, total sodium content of the tissue is elevated. This is caused by discontinuation of ion homeostasis, edema formation and membrane rupture. The situation is a different one in the chronic phase of scar formation, where cell migration causes changes in the ratio of extra- and intracellular volume. The accumulation of sodium causes an increase in the signal in 23Na magnetic resonance imaging. The differences in intra- and extracellular sodium concentration modulate total sodium content and can be used as a natural, intrinsic contrast. In animal experiments, 23Na magnetic resonance imaging allows the non-invasive determination of infarct size. As neither stunned nor hibernating tissue shows elevated total sodium content of the tissue, the method is able to discriminate viable and non-viable tissue. A small number of initial clinical studies show promising results for the use of this technique in humans. The development of 23Na magnetic resonance imaging and the current status of the application are described.
Keywords: Magnetic Resonance Imaging, myocardial viability, myocardial infarction, ion homeostasis
Current Vascular Pharmacology
Title: 23Na Magnetic Resonance Imaging for the Determination of Myocardial Viability: The Status and the Challenges
Volume: 2 Issue: 4
Author(s): Michael Horn
Affiliation:
Keywords: Magnetic Resonance Imaging, myocardial viability, myocardial infarction, ion homeostasis
Abstract: The determination of the extent of the non-viable tissue after myocardial infarction has a major impact on further treatment of patients. During acute myocardial infarction, total sodium content of the tissue is elevated. This is caused by discontinuation of ion homeostasis, edema formation and membrane rupture. The situation is a different one in the chronic phase of scar formation, where cell migration causes changes in the ratio of extra- and intracellular volume. The accumulation of sodium causes an increase in the signal in 23Na magnetic resonance imaging. The differences in intra- and extracellular sodium concentration modulate total sodium content and can be used as a natural, intrinsic contrast. In animal experiments, 23Na magnetic resonance imaging allows the non-invasive determination of infarct size. As neither stunned nor hibernating tissue shows elevated total sodium content of the tissue, the method is able to discriminate viable and non-viable tissue. A small number of initial clinical studies show promising results for the use of this technique in humans. The development of 23Na magnetic resonance imaging and the current status of the application are described.
Export Options
About this article
Cite this article as:
Horn Michael, 23Na Magnetic Resonance Imaging for the Determination of Myocardial Viability: The Status and the Challenges, Current Vascular Pharmacology 2004; 2 (4) . https://dx.doi.org/10.2174/1570161043385574
DOI https://dx.doi.org/10.2174/1570161043385574 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
Call for Papers in Thematic Issues
Ischemic Cardiovascular Diseases: Mechanisms, Diagnosis and Therapy
Ischemic cardiovascular disease includes myocardial infarction, coronary atherosclerotic heart disease, angina pectoris, etc., constitute the leading cause of patient mortality by preventing tissues from getting sufficient oxygen and nutrients. Ischemic heart disease, as a clinical condition, is characterized by myocardial ischemia, causing an imbalance between myocardial blood supply and demand, ...read more
TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE
Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Therapy Against Reperfusion-induced Microvascular Injury
Current Pharmaceutical Design The Anti-Inflammatory Role of Annexin-1 in Arthritis
Current Rheumatology Reviews Ischemic Colitis: Current Diagnosis and Treatment
Current Drug Targets Cardioprotection by Targeting the Pool of Resident and Extracardiac Progenitors
Current Drug Targets Metabolomics Analysis for Biomarker Discovery: Advances and Challenges
Current Medicinal Chemistry Therapeutic Angiogenesis for Islet Revascularization
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Leukotrienes and Atherosclerosis
Current Drug Targets IL-1 as a target in inflammation
Endocrine, Metabolic & Immune Disorders - Drug Targets Low-Molecular Weight Heparins in Percutaneous Coronary Interventions: Current Concepts, Problems, and Perspectives
Current Pharmaceutical Design Inflammatory Markers in Cardiovascular Disease; Lessons Learned and Future Perspectives
Current Vascular Pharmacology COVID-19 Severity: Lung-Heart Interplay
Current Cardiology Reviews Antiplatelet and Anticoagulation Strategies in the Prevention and Treatment of Ischemic Stroke
Current Pharmaceutical Design Cytochrome P450 in Neurological Disease
Current Drug Metabolism Regulation of Bcl-2 Family Proteins by Posttranslational Modifications
Current Molecular Medicine Antiplatelet Treatment in Stroke: New Insights
Current Pharmaceutical Design Adipokines and Myokines: A Pivotal Role in Metabolic and Cardiovascular Disorders
Current Medicinal Chemistry Treatment of Tachycardia in Hypertension: Where Do We Stand Now?
Current Hypertension Reviews MicroRNAs: An Apparent Switch for High-Altitude Pulmonary Edema
MicroRNA Why Is Homocysteine Toxic for the Nervous and Immune Systems?
Current Aging Science Lipoxygenase: An Emerging Target for Stroke Therapy
CNS & Neurological Disorders - Drug Targets